Consortium sells LAB901
Archangel Informal Investment, Alliance Trust, Scottish Enterprise, Foresight, Noble Fund Managers and the Business Growth Fund have exited their stake in LAB901.
The company, a developer and supplier of platform technology instruments that analyse DNA, RNA and protein fragments, was purchased by measurement company Agilent Technologies.
A team led by Janita Good from law firm Osborne Clarke advised the management team, while Mark Barron and colleagues from Taylor Wessing supported the acquirer.
Noble Fund Managers entered into LAB901 in August 2006, leading a £1.5m series-D funding round alongside existing investor Archangel.
More on Southern Europe
PE purchases stall in Italy as buyers lose faith – PE Forum Italy
PE players are hoping that valuation expectations will align in 2H 2023, easing dealmaking backlog
Fondo Agroalimentare Italiano invests in Urbis Food
Deal marks the fund’s full deployment with more than EUR 50m invested across nine transactions
Intesa Sanpaolo investment banking head exits for BNP Paribas
Marco Lattuada previously oversaw activities including M&A and debt capital markets at the Italian firm
William Blair launches Madrid office, adds investment banking practice in Zurich
Álvaro Hernández to lead new Spanish branch; healthcare will be first focus of Swiss expansion
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds